EVALUASI PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN HIPERTENSI DI INSTALASI RAWAT JALAN RUMAH SAKIT UMUM BHAKTI ASIH CILEDUG PERIODE OKTOBER-DESEMBER 2021

Main Article Content

Suny Koswara Suny

Abstract

Hypertension is an increase in systolic blood pressure exceeding 140 mmHg and diastolic blood pressure exceeding 90 mmHg in two measurements with an interval of five minutes in a state of sufficient rest or calm (Kemenkes, 2019). The purpose of this study was to determine the rationale for the use of antihypertensive drugs in hypertensive patients at the Outpatient Installation of Bhakti Asih General Hospital, Ciledug, October-December 2021. This study used a descriptive design with retrospective data collection. The data used in this study were medical record sheets of hypertension patients at Bhakti Asih General Hospital Ciledug for the period October-December 2021 with a Cross Sectional approach. This study used a simple random sampling technique and obtained 165 patients who met the inclusion criteria. Based on the results of the study, it is known that the characteristics of adult hypertensive patients based on age are the most elderly age >60 years, namely 95 patients (57.57%) and based on gender the most are women as many as 103 patients (62.42%). The most used class of drugs was the CCB group 69 patients (41.81%), the antihypertensive group that the single therapy was mostly used was 103 patients (66.43%), and the group of combination drugs used was the CCB+ARB group 48 patients ( 29.09%). Evaluation of rational drug prescribing on each criterion, namely 100% Right Patient, 100% Right Indication, 100% Right Drug, 97.58% Right Dose.

Article Details

How to Cite
Suny, S. K. (2023). EVALUASI PENGGUNAAN OBAT ANTIHIPERTENSI PADA PASIEN HIPERTENSI DI INSTALASI RAWAT JALAN RUMAH SAKIT UMUM BHAKTI ASIH CILEDUG PERIODE OKTOBER-DESEMBER 2021. Jurnal Farmasi IKIFA, 2(2), 89-100. Retrieved from https://epik.ikifa.ac.id/index.php/jfi/article/view/60
Section
Articles

References

Brunton, L.., Chabner, B. A., & Knollmann, B. C. (2018) Goodman & Gillman’s The Pharmacologycal Basis of Therapeurics, 13th Edition. In McGraw-Hill Companies.
Bianti Nuraini. (2015) Risk Factors Of Hypertension. Fakultas Kedokteran Universitas Lampung, Lampung.
Chiburdanidze, A., & Yulianti, T. (2019) Ketepatan Pemilihan Obat Antihipertensi Pada Pasien Hipertensi Rawat Jalan di Surakarta.URECOL (University Research Colloqium), 663–668.
Departemen Kesehatan Republik Indonesia. (2016) Pharmaceutical Care Untuk Penyakit Hipertensi, Depkes RI, Jakarta. Departemen Kesehatan Republik Indonesia. (2020) Pharmaceutical Care Untuk Penyakit Hipertensi, Depkes RI, Jakarta.
Dipiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., & Michael, P. L. (2015) Pharmacotherapy: A Pathophysiologic Approach, Third Edition. In McGraw-Hill Companies (Vol. 54, Issue 14). McGraw-Hill Company.
Hariawan, H., & Tatisina, C. M. (2020) Pelaksanaan Pemberdayaan Keluarga Dan Senam Hipertensi Sebagai Upaya Manajemen Diri Penderita Hipertensi. Jurnal Pengabdian Masyarakat Sasambo, 1(2), 75.
Hendarti, Hana Fitri. (2016) Evaluasi ketepatan obat dan dosis obat antihipertensi pada pasien hipertensi rawat jalan di puskesmas ciputat januaro-maret 2015,Skripsi Fakultas Kedokteran dan Ilmu Kesehatan, UIN Syarif Hidatarullah,Jakarta.
James PA, Oparil S, Carter BL, et al. (2014) Evidence-based guideline for the management of high blood pressure in adults. report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311 (5) : 507-520.
Jajuk Kusumawaty dkk. (2016) Hubungan Jenis Kelamin dengan Intensitas Hipertensi pada Lansia di Wilayah Kerja Puskesmas Lakbok Kabupaten Ciamis. Sekolah Tinggi Kesehatan Muhammadiyah Ciamis, Ciamis.
Karomatul Hidayah. (2017) Identifikasi Potensi Interaksi Obat pada Peresepan Obat Pasien Hipertensi dengan Diabetes Mellitus. Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Sebelas Maret Surakarta, Surakarta.
Kayce Bell, P. D.C. (2015), June Twiggs, P. D. C.(2015), & Bernie R.Olin,P.D. Hypertension : The Silent Killer : Updated JNC-8 Guideline.Albama Pharmacy Association, 1–8.
Kementerian Kesehatan (Kemenkes) Republik Indonesia. (2019). Pedoman Pelayanan Kefarmasian Pada Hipertensi. Jakarta: Kemenkes RI.Kemenkes (2009). Undang-Undang Republik Indonesia Nomor 44 Tahun 2009 Tentang Rumah Sakit. Jakarta:
Kemenkes RI. (2019) Pedoman Pelayanan Kefarmasian Pada Hipertensi. Departemen Kesehatan RI, 18–19.
Kemenkes. (2019) Modul Penggunaan Obat Rasional (POR). Jakarta: Kementrian Kesehatan RI.
Khairun Nisa. (2019). Menentukan Diagnosa dan Asuhan Keperawatan pada Pasien Hipertensi
Laura, A., Darmayanti, A., & Hasni, D. (2020) Evaluasi Penggunaan Obat Antihipertensi Di Puskesmas Ikur Koto Kota Padang Periode 2018. Human Care Journal, 5(2), 571– 572.
M Akib Yuswar. (2019) Pengukuran Kualitas Hidup Pasien Hipertensi di Puskesmas Perumnas I Kota Pontianak yang Menggunakan Antihipertensi melalui EQ5D Questionnaire dan VAS. Fakultas Kedokteran Universitas Tanjungpura, Pontianak.
Muhadi. (2016) JNC 8: Evidence-based Guideline Penanganan Pasien Hipertensi Dewasa. Fakultas Kedokteran Universitas Indonesia, Jakarta.
Notoatmodjo,S. (2012) Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta
Nuraini, B. (2015) Risk Factors of Hypertension.J Majority, 4(5), 10–19